Developing novel and affordable therapies against life threatening infections such as HIV and HBV
Viriom has raised €1.9M across 1 funding round from 2 investors, most recently a Early VC round in May 2016. Based in Khimki, Russia; founded 2009; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-05-01 | Early VC | €1.9M |
| ChemRar Ventures,Torrey Pines Investment |
| View deal → |
